Technical Analysis for OTIC - Otonomy Inc

Grade Last Price % Change Price Change
B 0.1180 8.26% 0.0090
OTIC closed up 8.26 percent on Friday, February 3, 2023, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Calm After Storm Range Contraction 8.26%
Doji - Bearish? Reversal 8.26%
Hot IPO Pullback Bullish Swing Setup 12.38%
New 52 Week Closing High Bullish 3.96%
Calm After Storm Range Contraction 3.96%
Inside Day Range Contraction 3.96%
New 52 Week Closing High Bullish 7.27%
Pocket Pivot Bullish Swing Setup 7.27%
Volume Surge Other 7.27%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% 20 days ago
Up 3% 20 days ago
Up 2% 20 days ago
Up 1% 20 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Otonomy Inc Description

Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the treatment of speech-in-noise hearing difficulties. It also develops OTO-510, an otoprotectant for the prevention of cisplatin-induced hearing loss; OTO-825, a gene therapy for the treatment of congenital hearing loss; and OTO-6XX induces hair cell repair and regeneration for the treatment of severe hearing loss. The company has license agreements with University of California and DURECT Corporation; and strategic collaboration with Applied Genetic Technologies Corporation to develop and commercialize gene therapy for congenital hearing loss. Otonomy, Inc. was incorporated in 2008 and is headquartered in San Diego, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Occupational Safety And Health Biopharmaceutical Organ Systems Gene Therapy Otology Audiology Otorhinolaryngology Perception University Of California

Is OTIC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.125
52 Week Low 0.087
Average Volume 1,000,834
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.1068
Average True Range 0.0137
RSI 68.15
ADX 0.0
+DI 23.2777
-DI 6.3674
Chandelier Exit (Long, 3 ATRs) 0.0839
Chandelier Exit (Short, 3 ATRs) 0.1281
Upper Bollinger Bands 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0034
MACD Signal Line 0.0016
MACD Histogram 0.0018
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1405
Resistance 3 (R3) 0.1397 0.1313 0.1368
Resistance 2 (R2) 0.1313 0.1256 0.1318 0.1355
Resistance 1 (R1) 0.1247 0.1221 0.1280 0.1255 0.1342
Pivot Point 0.1163 0.1163 0.1180 0.1168 0.1163
Support 1 (S1) 0.1097 0.1106 0.1130 0.1105 0.1018
Support 2 (S2) 0.1013 0.1071 0.1018 0.1005
Support 3 (S3) 0.0947 0.1013 0.0993
Support 4 (S4) 0.0955